Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Stereotactic-guided Biopsy Instrument Market Growth 2022-2028

  • LP 4928380
  • 100 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Stereotactic-guided Biopsy Instrument will have significant change from previous year. According to our (LP Information) latest study, the global Stereotactic-guided Biopsy Instrument market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Stereotactic-guided Biopsy Instrument market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Stereotactic-guided Biopsy Instrument market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Stereotactic-guided Biopsy Instrument market, reaching US$ million by the year 2028. As for the Europe Stereotactic-guided Biopsy Instrument landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Stereotactic-guided Biopsy Instrument players cover C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), and Devicor Medical Products, Inc., (Leica Biosystems) (Germany), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Stereotactic-guided Biopsy Instrument market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Needle-based Biopsy Instruments

Localization Wires

Procedure Trays

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Breast Biopsy

Lung Biopsy

Colorectal Biopsy

Prostate Biopsy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

C. R. Bard, Inc. (U.S.)

Becton, Dickinson and Company (U.S.)

Cook Group Incorporated (U.S.)

Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

Argon Medical Devices (U.S.)

B. Braun Melsungen AG (Germany)

Cardinal Health, Inc. (U.S.)

Olympus Corporation (Japan)

Boston Scientific Corporation (U.S.)

FUJIFILM Holdings Corporation (Japan)

INRAD, Inc. (U.S.)

Medtronic plc (Ireland)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Stereotactic-guided Biopsy Instrument Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Stereotactic-guided Biopsy Instrument by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Stereotactic-guided Biopsy Instrument by Country/Region, 2017, 2022 & 2028

2.2 Stereotactic-guided Biopsy Instrument Segment by Type

2.2.1 Needle-based Biopsy Instruments

2.2.2 Localization Wires

2.2.3 Procedure Trays

2.2.4 Others

2.3 Stereotactic-guided Biopsy Instrument Sales by Type

2.3.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

2.3.2 Global Stereotactic-guided Biopsy Instrument Revenue and Market Share by Type (2017-2022)

2.3.3 Global Stereotactic-guided Biopsy Instrument Sale Price by Type (2017-2022)

2.4 Stereotactic-guided Biopsy Instrument Segment by Application

2.4.1 Breast Biopsy

2.4.2 Lung Biopsy

2.4.3 Colorectal Biopsy

2.4.4 Prostate Biopsy

2.4.5 Others

2.5 Stereotactic-guided Biopsy Instrument Sales by Application

2.5.1 Global Stereotactic-guided Biopsy Instrument Sale Market Share by Application (2017-2022)

2.5.2 Global Stereotactic-guided Biopsy Instrument Revenue and Market Share by Application (2017-2022)

2.5.3 Global Stereotactic-guided Biopsy Instrument Sale Price by Application (2017-2022)

3 Global Stereotactic-guided Biopsy Instrument by Company

3.1 Global Stereotactic-guided Biopsy Instrument Breakdown Data by Company

3.1.1 Global Stereotactic-guided Biopsy Instrument Annual Sales by Company (2020-2022)

3.1.2 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Company (2020-2022)

3.2 Global Stereotactic-guided Biopsy Instrument Annual Revenue by Company (2020-2022)

3.2.1 Global Stereotactic-guided Biopsy Instrument Revenue by Company (2020-2022)

3.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Company (2020-2022)

3.3 Global Stereotactic-guided Biopsy Instrument Sale Price by Company

3.4 Key Manufacturers Stereotactic-guided Biopsy Instrument Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Stereotactic-guided Biopsy Instrument Product Location Distribution

3.4.2 Players Stereotactic-guided Biopsy Instrument Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Stereotactic-guided Biopsy Instrument by Geographic Region

4.1 World Historic Stereotactic-guided Biopsy Instrument Market Size by Geographic Region (2017-2022)

4.1.1 Global Stereotactic-guided Biopsy Instrument Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Stereotactic-guided Biopsy Instrument Annual Revenue by Geographic Region

4.2 World Historic Stereotactic-guided Biopsy Instrument Market Size by Country/Region (2017-2022)

4.2.1 Global Stereotactic-guided Biopsy Instrument Annual Sales by Country/Region (2017-2022)

4.2.2 Global Stereotactic-guided Biopsy Instrument Annual Revenue by Country/Region

4.3 Americas Stereotactic-guided Biopsy Instrument Sales Growth

4.4 APAC Stereotactic-guided Biopsy Instrument Sales Growth

4.5 Europe Stereotactic-guided Biopsy Instrument Sales Growth

4.6 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Growth

5 Americas

5.1 Americas Stereotactic-guided Biopsy Instrument Sales by Country

5.1.1 Americas Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022)

5.1.2 Americas Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022)

5.2 Americas Stereotactic-guided Biopsy Instrument Sales by Type

5.3 Americas Stereotactic-guided Biopsy Instrument Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Stereotactic-guided Biopsy Instrument Sales by Region

6.1.1 APAC Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022)

6.1.2 APAC Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022)

6.2 APAC Stereotactic-guided Biopsy Instrument Sales by Type

6.3 APAC Stereotactic-guided Biopsy Instrument Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Stereotactic-guided Biopsy Instrument by Country

7.1.1 Europe Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022)

7.1.2 Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022)

7.2 Europe Stereotactic-guided Biopsy Instrument Sales by Type

7.3 Europe Stereotactic-guided Biopsy Instrument Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Stereotactic-guided Biopsy Instrument by Country

8.1.1 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022)

8.1.2 Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022)

8.2 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Type

8.3 Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Stereotactic-guided Biopsy Instrument

10.3 Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument

10.4 Industry Chain Structure of Stereotactic-guided Biopsy Instrument

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Stereotactic-guided Biopsy Instrument Distributors

11.3 Stereotactic-guided Biopsy Instrument Customer

12 World Forecast Review for Stereotactic-guided Biopsy Instrument by Geographic Region

12.1 Global Stereotactic-guided Biopsy Instrument Market Size Forecast by Region

12.1.1 Global Stereotactic-guided Biopsy Instrument Forecast by Region (2023-2028)

12.1.2 Global Stereotactic-guided Biopsy Instrument Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Stereotactic-guided Biopsy Instrument Forecast by Type

12.7 Global Stereotactic-guided Biopsy Instrument Forecast by Application

13 Key Players Analysis

13.1 C. R. Bard, Inc. (U.S.)

13.1.1 C. R. Bard, Inc. (U.S.) Company Information

13.1.2 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 C. R. Bard, Inc. (U.S.) Main Business Overview

13.1.5 C. R. Bard, Inc. (U.S.) Latest Developments

13.2 Becton, Dickinson and Company (U.S.)

13.2.1 Becton, Dickinson and Company (U.S.) Company Information

13.2.2 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Becton, Dickinson and Company (U.S.) Main Business Overview

13.2.5 Becton, Dickinson and Company (U.S.) Latest Developments

13.3 Cook Group Incorporated (U.S.)

13.3.1 Cook Group Incorporated (U.S.) Company Information

13.3.2 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cook Group Incorporated (U.S.) Main Business Overview

13.3.5 Cook Group Incorporated (U.S.) Latest Developments

13.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

13.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Company Information

13.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Offered

13.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Main Business Overview

13.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Latest Developments

13.5 Argon Medical Devices (U.S.)

13.5.1 Argon Medical Devices (U.S.) Company Information

13.5.2 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Argon Medical Devices (U.S.) Main Business Overview

13.5.5 Argon Medical Devices (U.S.) Latest Developments

13.6 B. Braun Melsungen AG (Germany)

13.6.1 B. Braun Melsungen AG (Germany) Company Information

13.6.2 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Offered

13.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 B. Braun Melsungen AG (Germany) Main Business Overview

13.6.5 B. Braun Melsungen AG (Germany) Latest Developments

13.7 Cardinal Health, Inc. (U.S.)

13.7.1 Cardinal Health, Inc. (U.S.) Company Information

13.7.2 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.7.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cardinal Health, Inc. (U.S.) Main Business Overview

13.7.5 Cardinal Health, Inc. (U.S.) Latest Developments

13.8 Olympus Corporation (Japan)

13.8.1 Olympus Corporation (Japan) Company Information

13.8.2 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Offered

13.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Olympus Corporation (Japan) Main Business Overview

13.8.5 Olympus Corporation (Japan) Latest Developments

13.9 Boston Scientific Corporation (U.S.)

13.9.1 Boston Scientific Corporation (U.S.) Company Information

13.9.2 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Boston Scientific Corporation (U.S.) Main Business Overview

13.9.5 Boston Scientific Corporation (U.S.) Latest Developments

13.10 FUJIFILM Holdings Corporation (Japan)

13.10.1 FUJIFILM Holdings Corporation (Japan) Company Information

13.10.2 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Offered

13.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 FUJIFILM Holdings Corporation (Japan) Main Business Overview

13.10.5 FUJIFILM Holdings Corporation (Japan) Latest Developments

13.11 INRAD, Inc. (U.S.)

13.11.1 INRAD, Inc. (U.S.) Company Information

13.11.2 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

13.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 INRAD, Inc. (U.S.) Main Business Overview

13.11.5 INRAD, Inc. (U.S.) Latest Developments

13.12 Medtronic plc (Ireland)

13.12.1 Medtronic plc (Ireland) Company Information

13.12.2 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Offered

13.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Medtronic plc (Ireland) Main Business Overview

13.12.5 Medtronic plc (Ireland) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Stereotactic-guided Biopsy Instrument Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Stereotactic-guided Biopsy Instrument Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Needle-based Biopsy Instruments

Table 4. Major Players of Localization Wires

Table 5. Major Players of Procedure Trays

Table 6. Major Players of Others

Table 7. Global Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)

Table 8. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

Table 9. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2017-2022) & ($ million)

Table 10. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2017-2022)

Table 11. Global Stereotactic-guided Biopsy Instrument Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)

Table 13. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Table 14. Global Stereotactic-guided Biopsy Instrument Revenue by Application (2017-2022)

Table 15. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2017-2022)

Table 16. Global Stereotactic-guided Biopsy Instrument Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Stereotactic-guided Biopsy Instrument Sales by Company (2020-2022) & (K Units)

Table 18. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Company (2020-2022)

Table 19. Global Stereotactic-guided Biopsy Instrument Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Company (2020-2022)

Table 21. Global Stereotactic-guided Biopsy Instrument Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Stereotactic-guided Biopsy Instrument Producing Area Distribution and Sales Area

Table 23. Players Stereotactic-guided Biopsy Instrument Products Offered

Table 24. Stereotactic-guided Biopsy Instrument Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Stereotactic-guided Biopsy Instrument Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Stereotactic-guided Biopsy Instrument Sales Market Share Geographic Region (2017-2022)

Table 29. Global Stereotactic-guided Biopsy Instrument Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Stereotactic-guided Biopsy Instrument Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Country/Region (2017-2022)

Table 33. Global Stereotactic-guided Biopsy Instrument Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)

Table 36. Americas Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)

Table 37. Americas Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)

Table 39. Americas Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)

Table 40. Americas Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

Table 41. Americas Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)

Table 42. Americas Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Table 43. APAC Stereotactic-guided Biopsy Instrument Sales by Region (2017-2022) & (K Units)

Table 44. APAC Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)

Table 45. APAC Stereotactic-guided Biopsy Instrument Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2017-2022)

Table 47. APAC Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)

Table 48. APAC Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

Table 49. APAC Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)

Table 50. APAC Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Table 51. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)

Table 52. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)

Table 53. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)

Table 55. Europe Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)

Table 56. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

Table 57. Europe Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)

Table 58. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Stereotactic-guided Biopsy Instrument

Table 68. Key Market Challenges & Risks of Stereotactic-guided Biopsy Instrument

Table 69. Key Industry Trends of Stereotactic-guided Biopsy Instrument

Table 70. Stereotactic-guided Biopsy Instrument Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Stereotactic-guided Biopsy Instrument Distributors List

Table 73. Stereotactic-guided Biopsy Instrument Customer List

Table 74. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Stereotactic-guided Biopsy Instrument Sales Market Forecast by Region

Table 76. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Stereotactic-guided Biopsy Instrument Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Stereotactic-guided Biopsy Instrument Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Stereotactic-guided Biopsy Instrument Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Stereotactic-guided Biopsy Instrument Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Stereotactic-guided Biopsy Instrument Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Stereotactic-guided Biopsy Instrument Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Stereotactic-guided Biopsy Instrument Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Stereotactic-guided Biopsy Instrument Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Application (2023-2028)

Table 94. C. R. Bard, Inc. (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 95. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 96. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. C. R. Bard, Inc. (U.S.) Main Business

Table 98. C. R. Bard, Inc. (U.S.) Latest Developments

Table 99. Becton, Dickinson and Company (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 100. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 101. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Becton, Dickinson and Company (U.S.) Main Business

Table 103. Becton, Dickinson and Company (U.S.) Latest Developments

Table 104. Cook Group Incorporated (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 105. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 106. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Cook Group Incorporated (U.S.) Main Business

Table 108. Cook Group Incorporated (U.S.) Latest Developments

Table 109. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 110. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Offered

Table 111. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Main Business

Table 113. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Latest Developments

Table 114. Argon Medical Devices (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 115. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 116. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Argon Medical Devices (U.S.) Main Business

Table 118. Argon Medical Devices (U.S.) Latest Developments

Table 119. B. Braun Melsungen AG (Germany) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 120. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Offered

Table 121. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. B. Braun Melsungen AG (Germany) Main Business

Table 123. B. Braun Melsungen AG (Germany) Latest Developments

Table 124. Cardinal Health, Inc. (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 125. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 126. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Cardinal Health, Inc. (U.S.) Main Business

Table 128. Cardinal Health, Inc. (U.S.) Latest Developments

Table 129. Olympus Corporation (Japan) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 130. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Offered

Table 131. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Olympus Corporation (Japan) Main Business

Table 133. Olympus Corporation (Japan) Latest Developments

Table 134. Boston Scientific Corporation (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 135. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 136. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Boston Scientific Corporation (U.S.) Main Business

Table 138. Boston Scientific Corporation (U.S.) Latest Developments

Table 139. FUJIFILM Holdings Corporation (Japan) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 140. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Offered

Table 141. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. FUJIFILM Holdings Corporation (Japan) Main Business

Table 143. FUJIFILM Holdings Corporation (Japan) Latest Developments

Table 144. INRAD, Inc. (U.S.) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 145. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Offered

Table 146. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. INRAD, Inc. (U.S.) Main Business

Table 148. INRAD, Inc. (U.S.) Latest Developments

Table 149. Medtronic plc (Ireland) Basic Information, Stereotactic-guided Biopsy Instrument Manufacturing Base, Sales Area and Its Competitors

Table 150. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Offered

Table 151. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Medtronic plc (Ireland) Main Business

Table 153. Medtronic plc (Ireland) Latest Developments

List of Figures

Figure 1. Picture of Stereotactic-guided Biopsy Instrument

Figure 2. Stereotactic-guided Biopsy Instrument Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Stereotactic-guided Biopsy Instrument Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Stereotactic-guided Biopsy Instrument Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Stereotactic-guided Biopsy Instrument Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Needle-based Biopsy Instruments

Figure 10. Product Picture of Localization Wires

Figure 11. Product Picture of Procedure Trays

Figure 12. Product Picture of Others

Figure 13. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type in 2021

Figure 14. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2017-2022)

Figure 15. Stereotactic-guided Biopsy Instrument Consumed in Breast Biopsy

Figure 16. Global Stereotactic-guided Biopsy Instrument Market: Breast Biopsy (2017-2022) & (K Units)

Figure 17. Stereotactic-guided Biopsy Instrument Consumed in Lung Biopsy

Figure 18. Global Stereotactic-guided Biopsy Instrument Market: Lung Biopsy (2017-2022) & (K Units)

Figure 19. Stereotactic-guided Biopsy Instrument Consumed in Colorectal Biopsy

Figure 20. Global Stereotactic-guided Biopsy Instrument Market: Colorectal Biopsy (2017-2022) & (K Units)

Figure 21. Stereotactic-guided Biopsy Instrument Consumed in Prostate Biopsy

Figure 22. Global Stereotactic-guided Biopsy Instrument Market: Prostate Biopsy (2017-2022) & (K Units)

Figure 23. Stereotactic-guided Biopsy Instrument Consumed in Others

Figure 24. Global Stereotactic-guided Biopsy Instrument Market: Others (2017-2022) & (K Units)

Figure 25. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2017-2022)

Figure 26. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application in 2021

Figure 27. Stereotactic-guided Biopsy Instrument Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Company in 2021

Figure 29. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Geographic Region in 2021

Figure 31. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2017-2022)

Figure 32. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Country/Region in 2021

Figure 33. Americas Stereotactic-guided Biopsy Instrument Sales 2017-2022 (K Units)

Figure 34. Americas Stereotactic-guided Biopsy Instrument Revenue 2017-2022 ($ Millions)

Figure 35. APAC Stereotactic-guided Biopsy Instrument Sales 2017-2022 (K Units)

Figure 36. APAC Stereotactic-guided Biopsy Instrument Revenue 2017-2022 ($ Millions)

Figure 37. Europe Stereotactic-guided Biopsy Instrument Sales 2017-2022 (K Units)

Figure 38. Europe Stereotactic-guided Biopsy Instrument Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue 2017-2022 ($ Millions)

Figure 41. Americas Stereotactic-guided Biopsy Instrument Sales Market Share by Country in 2021

Figure 42. Americas Stereotactic-guided Biopsy Instrument Revenue Market Share by Country in 2021

Figure 43. United States Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Stereotactic-guided Biopsy Instrument Sales Market Share by Region in 2021

Figure 48. APAC Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions in 2021

Figure 49. China Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Country in 2021

Figure 56. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Country in 2021

Figure 57. Germany Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Country in 2021

Figure 64. Egypt Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Stereotactic-guided Biopsy Instrument Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Stereotactic-guided Biopsy Instrument in 2021

Figure 70. Manufacturing Process Analysis of Stereotactic-guided Biopsy Instrument

Figure 71. Industry Chain Structure of Stereotactic-guided Biopsy Instrument

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450